Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients with Crohn's Disease

被引：1
|
作者：
Wu, Kai-Chun [1 ]
Ran, Zhi Hua [2 ]
Gao, Xiang [3 ]
Chen, Minhu [4 ]
Zhong, Jie [5 ]
Sheng, Jian-Qiu [6 ]
Kamm, Michael A. [7 ,8 ]
Travis, Simon [9 ,10 ]
Robinson, Anne M.
Wallace, Kori
Shapiro, Marisa
Li, Yao
Thakkar, Roopal B.
机构：
[1] Fourth Mil Med Univ, Xijing Hosp, Xian, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Renji Hosptial, Huangpu, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[5] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China
[6] Beijing PLA, Mil Gen Hosp, Beijing, Peoples R China
[7] St Vincents Hosp Melbourne, Parkville, Vic, Australia
[8] Univ Melbourne, Parkville, Vic, Australia
[9] John Radcliffe Hosp, Oxford, England
[10] AbbVie Inc, N Chicago, IL USA
来源：
INFLAMMATORY BOWEL DISEASES | 2016年 / 22卷
关键词：
D O I：
10.1097/01.MIB.0000480212.77049.85
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-107
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [31] Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease
    Zittan, Eran
    Steinhart, A. Hillary
    Goldstein, Pavel
    Milgrom, Raquel
    Gralnek, Ian M.
    Silverberg, Mark S.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (10) : E00401
  • [32] Predictors of clinical response during adalimumab therapy in Crohn's disease patients: a German non-interventional study
    Blumenstein, I.
    Atreya, R.
    Greger, G.
    Bokemeyer, B.
    Nurwakagari, P.
    Neurath, M. F.
    Wittig, B.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S146 - S146
  • [33] Remission, Response, and Quality-of-Life Improvement in Patients with Crohn's Disease Treated with Adalimumab in the Access Trial
    Rutgeerts, Paul
    Loftus, Edward V.
    Binion, David G.
    McHugh, Kevin
    Chen, Naijun
    Guerette, Benoit
    Chao, Jingdong
    Mulani, Parvez
    GASTROENTEROLOGY, 2009, 136 (05) : A655 - A656
  • [34] Sustained steroid-free clinical remission in patients with moderate to severe Crohn's disease treated with adalimumab
    Hanauer, Stephen B.
    Kaam, M. A.
    Colombel, J. F.
    Sandborn, W. J.
    Rutgeerts, P.
    Kent, J. D.
    Pollack, P. F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S460 - S460
  • [35] Adalimumab rapidly induces clinical remission and response in patients with moderate to severe Crohn's disease who had secondary failure to infliximab therapy: Results of the GAIN study
    Sandborn, William J.
    Rutgeerts, P.
    Enns, R. A.
    Hanauer, S. B.
    Colombel, J. F.
    Panaccione, R.
    Kent, J. D.
    Pollack, P. F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S448 - S448
  • [36] Coherin™ peptides induce clinical response and remission in patients with active Crohn's disease
    Lichtenstein, GR
    Jacoby, HI
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S250 - S251
  • [37] Combination Therapy with Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis Induced Clinical Remission in a Crohn's Disease Patient with the Loss of Response to Scheduled Adalimumab Maintenance Therapy: A Case Report
    Ozeki, Keiji
    Tanida, Satoshi
    Mizushima, Takashi
    Mizoshita, Tsutomu
    Tsukamoto, Hironobu
    Hirata, Yoshikazu
    Murakami, Kenji
    Shimura, Takaya
    Kataoka, Hiromi
    Kamiya, Takeshi
    Joh, Takashi
    INTERNAL MEDICINE, 2012, 51 (06) : 595 - 599
  • [38] INDUCTION OF REMISSION WITH ADALIMUMAB IN PATIENTS WITH MODERATE CROHN'S DISEASE: SUBANALYSIS OF CLASSIC I
    Sandborn, W. J.
    Colombel, J-F
    Castillo, M. M.
    Zhou, Q.
    Thakkar, R. B.
    GUT, 2012, 61 : A228 - A229
  • [39] Induction of Remission with Adalimumab in Patients with Moderate Crohn's Disease: Subanalysis of CLASSIC I
    Sandborn, William
    Colombel, Jean-Frederic
    Castillo, Majin
    Zhou, Qian
    Thakkar, Roopal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S436 - S437
  • [40] Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease
    Mazor, Y.
    Almog, R.
    Kopylov, U.
    Ben Hur, D.
    Blatt, A.
    Dahan, A.
    Waterman, M.
    Ben-Horin, S.
    Chowers, Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (06) : 620 - 628
12345